Name: Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Karmanos Cancer Institute discusses Prostate Cancer Treatments: The Importance of Clinical Trials
Uploaded: 2021-10-12
Description: Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Karmanos Cancer Institute discusses the importance of clinical trials

Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Karmanos Cancer Institute discusses the importance of clinical trials for prostate cancer treatments.

2021 Summit, Clinical Strategies to Increase Patient Accrual, Clinical Trials, Enhancing Early Detection Treatments and Clinical Trials Education

african american mens health, black mens health, Elisabeth Heath, hbcu, health disparity rally, Karmanos Cancer Institute, MD, phen, phenpath, prostate cancer, prostate cancer crisis, prostate cancer treatments, prostate health education network

Posted on October 12, 2021

Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Karmanos Cancer Institute discusses Prostate Cancer Treatments: The Importance of Clinical Trials

Leave a Reply